INSIGHTS ON CLINICAL TRIAL PARTNERING
-
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them
Vendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
Clinical Leader Smart Sourcing Solutions Expo: Retention By Design
Enhance participant retention through intuitive UX and real-time site support tools, while seamlessly integrating with IRT, EDC, and third-party platforms.
-
Transform Relationship Management Into A Strategic Advantage
Discover how you can transform data management into a relationship-driven capability with the right partnership, achieving confidence, agility, and insight across the clinical trial lifecycle.
-
Building Bioanalysis Infrastructure For Modern Drug Development
Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.
-
The Hidden Cost Of Preferred Vendors10/21/2025
Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.
-
Podcast — Strategic Site Identification: A Proven Approach11/20/2024
Watch our new podcast to discover Altasciences' unique process for identifying and selecting the right clinical sites for your unique project.
-
Faster Starts, Stronger Finish: Operational Excellence In NSCLC5/22/2026
In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.
-
Effective Study Design And Execution Of Renal And Hepatic Impairment Trials5/1/2026
Master the complexities of renal and hepatic trials by leveraging site expertise and PK modeling to navigate recruitment challenges and ensure precise dosing for impaired populations.
-
Early Phase Clinical Trial Enrollment: How To Avoid Delays From The Start1/22/2026
By operationalizing the early-phase strategies discussed in this article, trial teams can ensure that foundational safety and efficacy data are captured without the delays that derail studies.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Inflammation is a primary pathogenic process in a wide range of diseases, including rheumatoid arthritis, cardiovascular disease, oncology and neuropsychiatric disorders.
-
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
The Avacare team expertly supports site operational needs through a proven, turnkey research infrastructure, giving clinical staff the freedom to focus on patient care delivery.
-
Join more than 1,000 research sites who use Advarra as their IBC of record. Is your research site ready to take advantage of this growing area of clinical trials?
-
Solve mission critical challenges and bring life-changing therapies to patients faster with Advarra Consulting.